Company news

Shanghai Opm Biosciences Co., Ltd. Class A (SSE:688293) news

Shanghai Opm Biosciences Co., Ltd. Class A news releases on 6ix. Latest, Sep 30, 2026: "SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Listing and Trading…

View Shanghai Opm Biosciences Co., Ltd. Class A →

Press releases & updates

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Listing and Trading of Restricted Shares from Private Placement of Shares in Connection with the Share Issuance and Cash Payment for Asset Acquisition and Raising of Supporting Funds

September 29, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Grant of Reserved Restricted Shares (First Batch) to Participants under the 2026 Restricted Share and Stock Appreciation Rights Incentive Plan

September 22, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Shareholding Reduction Plan by Specific Shareholder Holding Less Than 5% of Shares

September 14, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Departure of an Independent Director

September 11, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Completion of Industrial and Commercial Registration Changes and Issuance of a New Business License for a Wholly-owned Subsidiary

September 7, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Results of Shareholding Reduction by Shareholder

September 2, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Confirmation of the Cancellation of Certain Granted but Unvested Restricted Shares under the 2023 Restricted Share Incentive Plan

September 1, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Re-appointment of Accounting Firm

August 30, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Indicative Announcement on Change in Equity Interests of Shareholder Holding More Than 5% of Shares Reaching 1% and 5% Thresholds and Disclosure of Simplified Equity Change Report

August 10, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Initial Grant of Restricted Shares and Stock Appreciation Rights to Participants under the 2026 Restricted Share and Stock Appreciation Rights Incentive Plan

August 5, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

August 3, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Listing and Trading of First Batch of One-off Issued Restricted Shares from the Issuance of Shares and Payment of Cash for Asset Acquisition and Concurrent Fundraising

July 27, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License by the Company and Its Wholly-owned Subsidiaries

July 24, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026

July 22, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Use of Part of Idle Raised Funds for Cash Management

July 16, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Results of the Second Vesting of the Second Vesting Period for the Initially Granted Restricted Shares and the First Vesting Period for the Reserved Restricted Shares under the 2023 Restricted Stock Incentive Plan and the Listing of the Shares

July 14, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Results of Shareholding Reduction by Shareholders

July 10, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Completing Registered Capital Change Registration, Revision of the "Articles of Association" and Renewal of Business License

July 9, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Implementation of Dividend Distribution for 2025

July 5, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Indicative Announcement on Shareholding Changes of 5%+ Shareholder Reaching 1%/5% Scales and Triggering Abridged Equity Change Report Disclosure Obligations

July 3, 2026

"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on the Results of Issuance of Performance Commitment Shares for the First Fiscal Year of the Performance Commitment Period under Staged Issuance in Connection with Share Issuance and Cash Payment for Asset Acquisition and Fundraising, and Changes in Share Capital

June 30, 2026

Announcement on Equity Change of Specific Shareholders with Less than 5% Shares Reaching 1% Scale and Results of Shareholding Reduction

June 25, 2026

Announcement on the Phase I Issuance of the Phased Share Issuance in Asset Acquisition by Issuance of Shares and Cash Payment

June 24, 2026

Announcement on Arrangement for Performance Bet Shares for the 1st Fiscal Year of the Performance Commitment Period under the Installment Issuance of Shares and Cash Payment for Asset Acquisition and Supporting Fundraising

June 3, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 15, 2026

Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares

May 11, 2026

Announcement on Completion of Change in Registered Capital, Revision of "Articles of Association" and Renewal of Business License

May 6, 2026

Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference

April 30, 2026

Announcement on Resignation of Secretary of the Board of Directors

April 29, 2026

Announcement on Obtaining Government Subsidies

April 28, 2026

Announcement on 2025 Annual Profit Distribution Plan and 2026 Interim Dividend Distribution Plan

April 22, 2026

Announcement on Change of Sponsor Representative for Continuous Supervision and the Independent Financial Advisor for Continuous Supervision

April 17, 2026

Announcement on Issuing Shares and Paying Cash for Asset Acquisition, Raising of Supporting Funds, and the Results of Issuing Shares to Specific Objects by Raising Supporting Funds and Changes in Capital Stock

April 15, 2026

Indicative Announcement on the Disclosure of the Report on the Issuance of Shares and Payment of Cash for Asset Acquisition, Raising of Supporting Funds to Issue Shares to Specific Objects

April 8, 2026

Announcement on Resolutions of the 20th Meeting of the 2nd Board of Directors

March 6, 2026

Announcement on Preliminary Earnings Estimate for 2025

February 27, 2026

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License for Wholly-owned Subsidiary

February 13, 2026

Announcement on Completion of Fund Filing for the Industry Fund Participated in Its Establishment

February 9, 2026

Announcement on Results of the Issuance of Shares and Payment of Cash to Acquire Assets and Raise Supporting Funds, and Changes in Share Capital

February 8, 2026

SHANGHAI OPM BIOSCIENCES CO., LTD.: Announcement on Provision for Asset Impairment for 2025

January 30, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

January 16, 2026

Announcement on Completing Transfer of Underlying Assets Related to the Company's Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds

January 14, 2026

Announcement on Voluntary Disclosure of the Company and Wholly-owned Subsidiary Certified as High-tech Enterprises

January 9, 2026

Announcement on Resolutions of the 18th Meeting of the 2nd Board of Directors

December 31, 2025

Announcement on Progress in Participating in the Establishment of Industrial Funds

December 22, 2025

Announcement on Resignation of Independent Director

December 15, 2025

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License

December 10, 2025

Indicative Announcement on Reply to Regulatory Inquiry Regarding the Issuance of Shares and Cash Payment for Asset Acquisition with Supporting Fund-raising (Revised Draft)

December 9, 2025

Announcement on Approval by the Shanghai Stock Exchange M&A and Restructuring Review Committee for the Company's Issuance of Shares and Cash Payment to Purchase Assets and Raise Supporting Funds

December 8, 2025

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

December 1, 2025

Older →